"This expansion demonstrates our commitment to, and support of, research and development as a critical component of our future success," Joseph C. Scodari, worldwide chairman of J&J Pharmaceuticals, said in a statement. "More than 15 important new products have been discovered or developed here" and "we intend to continue building on that tradition."
Johnson & Johnson's other early-stage drug-discovery research "hubs" are in La Jolla, Calif., and Beerse, Belgium, the company said.
Gov. Rendell, who was in Spring House for the official groundbreaking, presented a $2.275 million check to the drug company for job training and economic development connected with the building expansion.
Rendell said Johnson & Johnson's expansion in Montgomery County and planned creation of 120 jobs over the next three years "shows how Pennsylvania's competitive business climate and strategic investments in rapidly growing industries" can create more opportunities for residents.
"Johnson & Johnson's decision to expand its Pennsylvania operations is a prime example of how our efforts to improve the state's business climate are producing results," Rendell said.
Contact staff writer Linda Loyd at 215-854-2831 or lloyd@phillynews.com.
